Medical Developments International Limited (MVP.AX)
AUD 0.4
(-2.47%)
AUD 0.4
(-2.47%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -10.78 Million | -16.49 Million | -10.72 Million | -8.8 Million | 601 Thousand | 21.27 Million |
| Net Income | -40.99 Million | -5.6 Million | -12.4 Million | -12.56 Million | 379 Thousand | 1.03 Million |
| Depreciation & Amortization | 3.39 Million | 3.11 Million | 2.94 Million | 3.74 Million | 2.59 Million | 1.18 Million |
| Deferred income taxes | - | -7.37 Million | -8.44 Million | -131 Thousand | 2.01 Million | -1.04 Million |
| Stock-based compensation | - | 1.25 Million | 1.02 Million | 1.16 Million | 91 Thousand | 380 Thousand |
| Change in working capital | 4.17 Million | -2.5 Million | -3.59 Million | -9.92 Million | -213 Thousand | -1.94 Million |
| Other non-cash items | 33.21 Million | -5.38 Million | 9.75 Million | 8.89 Million | -4.27 Million | 21.65 Million |
| Investing Cash Flow | -3.16 Million | -7.66 Million | -5.21 Million | -6.56 Million | -8.9 Million | -9.53 Million |
| Investments in PPE | -3.16 Million | -7.66 Million | -5.21 Million | -6.56 Million | -8.9 Million | -1.48 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -2.37 Million | -5.31 Million | -3.96 Million | -5.23 Million | -6.98 Million | -8.04 Million |
| Financing Cash Flow | -807 Thousand | 28.06 Million | 142 Thousand | 36.11 Million | -1.96 Million | 13.04 Million |
| Debt repayment | - | -253 Thousand | -215 Thousand | -91 Thousand | -91 Thousand | -9.07 Million |
| Dividends payments | - | - | - | - | -2.06 Million | -1.71 Million |
| Common Stock Repurchased | -533 Thousand | -1.68 Million | -3000.00 | -727 Thousand | -13 Thousand | -1.04 Million |
| Common Stock Issuance | - | 28.31 Million | 357 Thousand | 36.34 Million | 387 Thousand | 23.83 Million |
| Other Financing Activities | -274 Thousand | 28.06 Million | 142 Thousand | 36.11 Million | -184 Thousand | 1.04 Million |
| Accounts receivables | 1.86 Million | -2.87 Million | -2.5 Million | 1.43 Million | 2.3 Million | -2.09 Million |
| Accounts payables | -5.26 Million | 4.82 Million | 2.34 Million | 1.01 Million | 1.97 Million | 202 Thousand |
| Inventory | -393 Thousand | -1.84 Million | -1.37 Million | 154 Thousand | -2.83 Million | 148 Thousand |
| Other working capital | 7.97 Million | -2.61 Million | -2.06 Million | -12.52 Million | -1.65 Million | -202 Thousand |
| Cash at beginning of period | 24.66 Million | 20.39 Million | 36.27 Million | 15.54 Million | 25.62 Million | 794 Thousand |
| Cash at end of period | 9.73 Million | 24.66 Million | 20.39 Million | 36.27 Million | 15.54 Million | 25.62 Million |
| Capital Expenditure | -3.16 Million | -7.66 Million | -5.21 Million | -6.56 Million | -8.9 Million | -1.48 Million |
| Effect of forex changes on cash | -170 Thousand | 360 Thousand | -85 Thousand | -14 Thousand | 190 Thousand | 47 Thousand |
| Net cash flow / Change in cash | -14.92 Million | 4.26 Million | -15.87 Million | 20.73 Million | -10.07 Million | 24.82 Million |
| Free Cash Flow | -13.94 Million | -24.16 Million | -15.93 Million | -15.36 Million | -8.3 Million | 19.78 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -30.04 Million | -40.99 Million | -10.94 Million | -5.6 Million | -8.26 Million | 2.65 Million |
| Depreciation & Amortization | 1.86 Million | 3.39 Million | 1.52 Million | 3.11 Million | 1.52 Million | 1.58 Million |
| Deferred income taxes | - | - | -9.31 Million | -7.37 Million | -2.73 Million | -4.63 Million |
| Stock-based compensation | - | - | 5.57 Million | 1.25 Million | 1.28 Million | -25 Thousand |
| Change in working capital | 6.92 Million | 4.17 Million | -2.74 Million | -2.5 Million | -1.12 Million | -1.37 Million |
| Other non-cash items | 23.76 Million | 33.21 Million | 9.45 Million | -5.38 Million | 1.59 Million | -6.97 Million |
| Investing Cash Flow | -1.55 Million | -3.16 Million | -1.61 Million | -7.66 Million | -4.83 Million | -2.83 Million |
| Investments in PPE | -1.55 Million | -3.16 Million | -1.61 Million | -7.66 Million | -4.83 Million | -2.83 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -727 Thousand | -5.31 Million | -3.45 Million | -1.86 Million |
| Financing Cash Flow | -140 Thousand | -807 Thousand | -667 Thousand | 28.06 Million | -171 Thousand | 28.23 Million |
| Debt repayment | - | - | -134 Thousand | -253 Thousand | - | -124 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -533 Thousand | -533 Thousand | -1.68 Million | - | - |
| Common Stock Issuance | - | - | - | 28.31 Million | -42 Thousand | 28.35 Million |
| Other Financing Activities | -140 Thousand | - | -533 Thousand | 28.06 Million | -171 Thousand | 28.35 Million |
| Accounts receivables | -2.59 Million | 1.86 Million | 4.45 Million | -2.87 Million | -3.19 Million | 324 Thousand |
| Accounts payables | -920 Thousand | -5.26 Million | -4.34 Million | 4.82 Million | 3.16 Million | 1.66 Million |
| Inventory | 413 Thousand | -393 Thousand | -806 Thousand | -1.84 Million | 1.63 Million | -3.47 Million |
| Other working capital | 10.02 Million | 7.97 Million | -2.05 Million | -2.61 Million | -845 Thousand | 112 Thousand |
| Cash at beginning of period | 15.69 Million | 24.66 Million | 24.66 Million | 20.39 Million | 37.12 Million | 20.39 Million |
| Cash at end of period | 9.73 Million | 9.73 Million | 15.69 Million | 24.66 Million | 24.66 Million | 37.12 Million |
| Capital Expenditure | -1.55 Million | -3.16 Million | -1.61 Million | -7.66 Million | -4.83 Million | -2.83 Million |
| Effect of forex changes on cash | - | - | -230 Thousand | 360 Thousand | 267 Thousand | 93 Thousand |
| Net cash flow / Change in cash | -5.96 Million | -14.92 Million | -8.96 Million | 4.26 Million | -12.46 Million | 16.72 Million |
| Free Cash Flow | -5.88 Million | -13.94 Million | -8.06 Million | -24.16 Million | -12.55 Million | -11.6 Million |
002824
GEM
CONXF
600211
LABS
TBEV